PL2744831T3 - Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania - Google Patents

Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania

Info

Publication number: PL2744831T3
Authority: PL; Poland
Prior art keywords: transferrin; producing; methods; same; fusion protein
Prior art date: 2011-08-17

Application number

PL12824616T

Other languages

English (en)

Inventor

Uday B. Kompella

Robert I. SCHEINMAN

Puneet Tyagi

Original Assignee

The Regents Of The University Of Colorado, A Body Corporate

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-17

Filing date

2012-08-15

Publication date

2018-05-30

2012-08-15 Application filed by The Regents Of The University Of Colorado, A Body Corporate filed Critical The Regents Of The University Of Colorado, A Body Corporate

2018-05-30 Publication of PL2744831T3 publication Critical patent/PL2744831T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL12824616T 2011-08-17 2012-08-15 Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania PL2744831T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201161524508P	2011-08-17	2011-08-17
EP12824616.2A EP2744831B1 (en)	2011-08-17	2012-08-15	Transferrin-tumstatin fusion protein and methods for producing and using the same
PCT/US2012/051013 WO2013025846A2 (en)	2011-08-17	2012-08-15	Transferrin-tumstatin fusion protein and methods for producing and using the same

Publications (1)

Publication Number	Publication Date
PL2744831T3 true PL2744831T3 (pl)	2018-05-30

Family

ID=47715692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL12824616T PL2744831T3 (pl)	2011-08-17	2012-08-15	Białko fuzyjne transferryna-tumstatyna oraz sposoby jego wytwarzania i stosowania

Country Status (15)

Country	Link
US (1)	US9290562B2 (pl)
EP (1)	EP2744831B1 (pl)
JP (1)	JP6073888B2 (pl)
CN (2)	CN110105453A (pl)
AU (1)	AU2012296588B2 (pl)
BR (1)	BR112014008680A2 (pl)
CA (1)	CA2849015C (pl)
DK (1)	DK2744831T3 (pl)
ES (1)	ES2659161T3 (pl)
NO (1)	NO2820418T3 (pl)
PL (1)	PL2744831T3 (pl)
PT (1)	PT2744831T (pl)
SI (1)	SI2744831T1 (pl)
TR (1)	TR201802686T4 (pl)
WO (1)	WO2013025846A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014180288A1 (zh) *	2013-05-06	2014-11-13	中国药科大学	具有抑制肿瘤微环境血管再生和激活适应性免疫应答双功能的融合蛋白及其基因和应用
JP2016522249A (ja) *	2013-06-20	2016-07-28	ノバルティスアーゲー	脈絡膜血管新生の治療におけるｖｅｇｆアンタゴニストの使用
US11058750B2 (en) *	2015-12-03	2021-07-13	Mor Research Applications Ltd.	Compositions and methods for treatment of ocular diseases
KR101818151B1 (ko)	2016-03-25	2018-01-16	한국과학기술원	트렌스페린을 포함하는 허혈성망막병증 예방 및 치료용 조성물
CN109053899B (zh) *	2017-12-22	2021-11-16	湖南远泰生物技术有限公司	一种含人转铁蛋白抗原表位序列的嵌合体抗原受体

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5672683A (en)	1989-09-07	1997-09-30	Alkermes, Inc.	Transferrin neuropharmaceutical agent fusion protein
US20050192242A1 (en)	1995-10-11	2005-09-01	Neal Zane C.	Therapeutic fusion protein transgenes
AU753249B2 (en) *	1998-06-17	2002-10-10	Beth Israel Deaconess Medical Center	Anti-angiogenic proteins and methods of use thereof
JP2003517847A (ja)	1999-12-23	2003-06-03	ヒューマンジノームサイエンシーズ，インコーポレイテッド	トランスフェリンポリヌクレオチド、ポリペプチド、および抗体
US8129504B2 (en) *	2001-08-30	2012-03-06	Biorexis Technology, Inc.	Oral delivery of modified transferrin fusion proteins
CA2457520A1 (en)	2001-08-30	2003-03-13	Biorexis Pharmaceutical Corporation	Modified transferrin fusion proteins
EP2277910A1 (en)	2001-12-21	2011-01-26	Human Genome Sciences, Inc.	Albumin fusion proteins
NZ534492A (en) *	2002-02-07	2009-10-30	Novozymes Delta Ltd	Albumin-fused kunitz domain peptides
EP1670428A4 (en)	2003-10-10	2008-03-12	Univ Southern California	HYBRID PROTEINS G-CSF-TRANSFERRIN
EP1722762A2 (en) *	2004-03-02	2006-11-22	Massachusetts Institute of Technology	Nanocell drug delivery system
US20080207502A1 (en) *	2004-10-14	2008-08-28	Sopherion Therapeutics, Inc.	Anti-Angiogenic Peptides and Methods of Use Thereof
WO2006049983A2 (en)	2004-10-27	2006-05-11	Biorexis Pharmaceutical Corporation	Peptide yy modified transferrin fusion proteins
EP1881849A2 (en) *	2005-04-29	2008-01-30	Research Development Foundation	Vascular targeting of ocular neovascularization
EP1988915B1 (en)	2006-02-03	2012-03-28	Crc For Asthma And Airways Ltd	Tumstatin for the treatment of conditions associated with airway tissue remodeling
CN101070349B (zh) *	2007-05-22	2010-10-13	山西康宝生物制品股份有限公司	具有选择性杀伤肿瘤新生血管内皮细胞作用的融合蛋白与应用
CN101092452A (zh) *	2007-05-23	2007-12-26	哈尔滨医科大学	肿瘤抑素抗血管生成小分子多肽、融合蛋白及两者制备方法
US7943733B2 (en) *	2007-12-20	2011-05-17	University Of Southern California	Spacers to increase the expression of recombinant fusion proteins
JP6101638B2 (ja)	2011-03-03	2017-03-22	ザイムワークス，インコーポレイテッド	多価ヘテロマルチマー足場設計及び構築物

2012
- 2012-08-15 PL PL12824616T patent/PL2744831T3/pl unknown
- 2012-08-15 CN CN201910156923.9A patent/CN110105453A/zh active Pending
- 2012-08-15 EP EP12824616.2A patent/EP2744831B1/en active Active
- 2012-08-15 DK DK12824616.2T patent/DK2744831T3/en active
- 2012-08-15 CA CA2849015A patent/CA2849015C/en active Active
- 2012-08-15 PT PT128246162T patent/PT2744831T/pt unknown
- 2012-08-15 JP JP2014526189A patent/JP6073888B2/ja active Active
- 2012-08-15 ES ES12824616.2T patent/ES2659161T3/es active Active
- 2012-08-15 SI SI201231232T patent/SI2744831T1/en unknown
- 2012-08-15 AU AU2012296588A patent/AU2012296588B2/en active Active
- 2012-08-15 US US14/239,176 patent/US9290562B2/en active Active
- 2012-08-15 WO PCT/US2012/051013 patent/WO2013025846A2/en not_active Ceased
- 2012-08-15 BR BR112014008680A patent/BR112014008680A2/pt unknown
- 2012-08-15 CN CN201280051256.4A patent/CN103998470A/zh active Pending
- 2012-08-15 TR TR2018/02686T patent/TR201802686T4/tr unknown
2013
- 2013-07-22 NO NO13745268A patent/NO2820418T3/no unknown

Also Published As

Publication number	Publication date
EP2744831A2 (en)	2014-06-25
AU2012296588B2 (en)	2017-07-27
JP6073888B2 (ja)	2017-02-01
DK2744831T3 (en)	2018-03-05
WO2013025846A3 (en)	2013-05-02
BR112014008680A2 (pt)	2017-06-13
JP2014526890A (ja)	2014-10-09
CN110105453A (zh)	2019-08-09
AU2012296588A1 (en)	2014-04-03
PT2744831T (pt)	2018-03-05
EP2744831B1 (en)	2017-12-06
US9290562B2 (en)	2016-03-22
CA2849015A1 (en)	2013-02-21
TR201802686T4 (tr)	2018-03-21
EP2744831A4 (en)	2015-03-11
CA2849015C (en)	2017-08-08
SI2744831T1 (en)	2018-04-30
WO2013025846A2 (en)	2013-02-21
US20140179612A1 (en)	2014-06-26
CN103998470A (zh)	2014-08-20
NO2820418T3 (pl)	2018-05-05
ES2659161T3 (es)	2018-03-14

Publication	Publication Date	Title
PT2697187T (pt)	2020-06-16	Olefinas e métodos para produção das mesmas
IL240898A0 (en)	2015-10-29	Antibodies against a5c and methods of using the antibodies
EP2699719A4 (en)	2014-09-24	TUBULAR STRUCTURE AND MANUFACTURING METHOD THEREFOR
GB201115529D0 (en)	2011-10-26	Antibodies, uses and methods
GB201115280D0 (en)	2011-10-19	Antibodies, uses and methods
IL233757A0 (en)	2014-09-30	Anti '1m e-gi antibodies and methods of using them
HUE048848T2 (hu)	2020-08-28	Fúziós fehérjék és kombinált oltóanyagok
IL232743A0 (en)	2014-07-31	anticancer fusion protein
ZA201400562B (en)	2017-06-28	Axmi205 variant proteins and methods for their use
SG10201604332XA (en)	2016-07-28	Membrane and method for making the same
SG10202100341XA (en)	2021-02-25	Npp1 fusion proteins
LT2661496T (lt)	2017-07-10	Priešvėžinis sulietas baltymas
ZA201405460B (en)	2015-04-29	Anticancer fusion protein
EP2698386B8 (en)	2018-02-07	Fusion protein
EP2657337A4 (en)	2014-09-17	FUSION PROTEIN
ZA201308597B (en)	2014-12-23	Anticancer fusion protein
EP2718432A4 (en)	2015-01-07	NUCLEASE FUSION PROTEIN AND USES THEREOF
PT2744831T (pt)	2018-03-05	Proteína de fusão de transferrina-tumstatina e métodos para a produzir e utilizar
ZA201207425B (en)	2014-03-26	Fusion protein
SG2014008601A (en)	2014-04-28	Method for producing clean packageing material and the clean packageing material
GB201107189D0 (en)	2011-06-15	Fusion proteins
GB201114701D0 (en)	2011-10-12	Fusion proteins
AU2011905145A0 (en)	2012-01-12	Fusion Protein
AU2011902431A0 (en)	2011-07-07	Fusion Proteins and Use Thereof
GB201007955D0 (en)	2010-06-30	Somatosatin fusion proteins